Appearance of New Cutaneous Superficial Basal Cell Carcinomas during Successful Nivolumab Treatment of Refractory Metastatic Disease: Implications for Immunotherapy in Early Versus Late Disease

類似資料

• JAK1 Genomic Alteration Associated With Exceptional Response to Siltuximab in Cutaneous Castleman Disease
  著者:: Patel, Maulik, 等
  出版事項: (2017)
• Rare Tumor Clinic: The University of California San Diego Moores Cancer Center Experience with a Precision Therapy Approach
  著者:: Kato, Shumei, 等
  出版事項: (2017)
• Metastatic basal cell carcinoma with amplification of PD-L1: exceptional response to anti-PD1 therapy
  著者:: Ikeda, Sadakatsu, 等
  出版事項: (2016)
• Cutaneous Metastatic Cancer: Carcinoma Hemorrhagiectoides Presenting as the Shield Sign
  著者:: Cohen, Philip R, 等
  出版事項: (2021)
• Hyper-progressors after Immunotherapy: Analysis of Genomic Alterations Associated with Accelerated Growth Rate
  著者:: Kato, Shumei, 等
  出版事項: (2017)